[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2010/122089,2010,A1Locationinpatent:Page/Pagecolumn130
403646-46-8
685126-86-7
954235-88-2
220996-81-6
2155854-99-0
2165137-21-1
1255099-58-1 | 2-(N-Boc-aminomethyl)-3-(4-fluorophenyl)propionic acid | AA000NPG | MFCD17926364
1256345-87-5 | 3-Ethoxy-5-(trifluoromethoxy)phenylboronic acid | AA000NY0 | MFCD16295059
1256355-63-1 | 4-(2-Fluoroethoxy)phenylboronic acid | AA000O2I | MFCD17214255
1256643-55-6 | 5,7-Dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonyl chloride | AA000O83 | MFCD18381909
125700-73-4 | TNTU | AA000OF4 | MFCD00167753
1257849-07-2 | Fmoc-5-chloro-l-tryptophan | AA000OMR | MFCD16883066
1190-92-7 | 1-Dimethylamino-2-nitroethylene | AA000OYN | MFCD00051519
1196155-35-7 | 3,5-Dibromopyridazine | AA000P93 | MFCD18403740
1197239-37-4 | tert-Butyl (3-aminocyclopentyl)carbamate hydrochloride | AA000PHF | MFCD09759162
1198615-70-1 | (3-Ethoxycarbonylmethyl)phenylboronic acid, pinacol ester | AA000PPO | MFCD08704682